# Insulin Aspart

Canonical source: https://retacompare.com/encyclopedia/insulin-aspart

Rapid-acting prandial insulin analog.

Reference facts

Also known asNovoLog, FiaspCategoryHormonal & PituitaryMechanism of actionRapid-acting prandial insulin analog.TargetsInsulin receptorIndications under research or approvedDiabetes — prandial insulinRegulatory status (reference entry)FDA-approved (2000)Half-life~1 hourSequenceGIVEQCCTSICSLYQLENYCNSequence notesRapid-acting insulin: B-chain Pro28 → Asp, reducing dimerization.Molecular weight (Da)5826PDB accession1ZEHOriginator / sponsorNovo NordiskFirst reported1994
    Primary References

NovoLog FDA label


    Explore research articles about Insulin Aspart


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- NovoLog FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020986s086lbl.pdf